Presentation LAA 2017 Pre-Procedural Imaging to Characterize the PFO: TTE, TEE, TCD Presenter: Zahid Amin July 22, 2017
Presentation LAA 2017 My 3 Most Challenging Transseptal Punctures in 5 Minutes Presenter: Brian Whisenant July 22, 2017
Presentation LAA 2017 Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure? Presenter: Vivek Y. Reddy July 21, 2017
News Conference News EuroPCR 2017 EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure Michael O'Riordan May 24, 2017
News Daily News ‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry Todd Neale May 17, 2017
News Conference News SCAI 2017 New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke L.A. McKeown May 12, 2017
Presentation SWVS 2017 Cases: The Good, The Bad and The Ugly Presenter: Michael J. Reardon May 07, 2017
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time Shelley Wood March 23, 2017
News Conference News ACC 2017 Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients L.A. McKeown March 21, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2017 Shelley Wood March 01, 2017
News Conference News CRT 2017 Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation Michael O'Riordan February 22, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2017 Caitlin E. Cox February 01, 2017
News Features The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol Michael O'Riordan January 24, 2017
News Daily News Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings Shelley Wood January 19, 2017
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017
Presentation Apixaban in Patients With Atrial Fibrillation After TAVR Presenter: J. Seeger January 03, 2017